The genomics is defined as the study of a gene and its functioning. Genomics is used to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. The major factors attributing to the growth of the genomics market are growing government support and increased number of genomics studies, declining sequencing cost, increased genomics applications.
Thermo Fisher Scientific Inc, and Illumina, Inc – Notable Market Players in Genomics Market
Market leaders operating in the market have undertaken various organic growth strategies in the Genomics market. The Genomics market majorly consists of the players Illumina, Inc., Danaher, F. HOFFMANN-LA ROCHE LTD., BIO-RAD LABORATORIES INC., General Electric Company, THERMO FISHER SCIENTIFIC INC., Agilent Technologies, Inc., Eurofins Scientific, QIAGEN, BGI. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.
Below is the list of the growth strategies done by the players operating in the Genomics market:
| Year | News |
| Dec-2020 | Beckman Coulter launched a new test that addresses the three main barriers currently facing businesses, schools, hospitals, and communities with the rollout of mass COVID-19 testing. |
| Nov-2020 | Beckman Coulter announced the launch of its Access SARS-CoV-2 IgG II assay that estimates a patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection. |
| Nov-2020 | QIAGEN N.V. announced the European launch of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test that will assist healthcare professionals quickly identify and distinguish between patients with common seasonal respiratory infections and COVID-19. |
| Nov-2020 | BGI Genomics announced that the Real-time Fluorescent RT-PCR kit manufactured by BGI Biotechnology (Wuhan) for detecting 2019-nCoV, received registration by the national sanitary surveillance agency of Brazil (ANVISA) as a Class III In-vitro diagnostic device. |
